Trial Profile
Study of adenosine A2A receptor antagonist istradefylline in patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2018
Price :
$35
*
At a glance
- Drugs Istradefylline (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- 26 Sep 2018 New trial record
- 31 Aug 2018 Results presented at the 48th Annual Meeting of the International Continence Society